You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 30171 - 30180 of 35373 results
  1. Identification of Novel Immunosuppressant Target(s)

    SBC: Bionetics Corp.            Topic: N/A

    Rapamycin is a promising therapeutic agent because of its potent antiproliferative and immunosuppressive activities. The goal of this project is to identify the cellular target of rapamycin which mediates its antiproliferative/immunosuppressive activity. During Phase I study, we will identify the FKBP-l2 surface residue mutants, i. e., residues involved in protein-protein interaction that confer r ...

    SBIR Phase I 1993 Department of Health and Human Services
  2. Three-Dimensional Imaging of Tumors Through Tissue

    SBC: MEDISPECTRA, INC.            Topic: N/A

    We will apply a new, non-invasive, non-contacting technique, Laser Heterodyne Imaging (LHI), to 3-dimensional imaging of neoplasms. Preliminary measurements have been made through ~1mm of mouse skin and in 1.4mm phantoms, using dyes similar to those used in PDT. With improved apparatus, our goal is several millimeters penetration. LHI measures intensity-modulated fluorescence originating from the ...

    SBIR Phase I 1993 Department of Health and Human Services
  3. SUPPOSITORIES FOR RAPID ANTI-EPILEPTIC DIAZEPAM DELIVERY

    SBC: BIOTEK, INC.            Topic: N/A

    THE CONTRACTOR SHALL PREPARE EXPERIMENTAL SUPPOSITORIES, TEST THEM IN RABBITS, MAKE INDICATED MODIFICATIONS, AND DEMONSTRATE THAT THESE SUPPOSITORIES HAVE PRACTICAL POTENTIAL FOR RAPID TREATMENT OF CONVULSIONS IN HUMAN BEINGS. THE CONTRACTOR SHALL PREPARE EXPERIMENTAL SUPPOSITORIES, TEST THEM IN RABBITS, MAKE INDICATED MODIFICATIONS, AND DEMONSTRATE THAT THESE SUPPOSITORIES HAVE PRACTICAL POTENTIA ...

    SBIR Phase II 1993 Department of Health and Human Services
  4. AN ESTROGEN-PROGESTIN PATCH FOR ESTROGEN REPLACEMENT

    SBC: BIOTEK, INC.            Topic: N/A

    THE OBJECTIVE OF THIS RESEARCH APPLICATION IS TO UTILIZE BIOTEK'S TRANSDERMAL DRUG DELIVERY SYSTEM FOR THE DEVELOPMENT OF A SUSTAINED TRANSDERMAL DELIVERY SYSTEM FOR ESTRADIOL AND LEVONORGESTREL FOR USE IN ESTROGEN REPLACEMENT THERAPY. CONDITIONS FOR ESTRADIOL AND LEVONORGESTREL TRANSDERMAL DELIVERY WERE PREVIOUSLY DEVELOPED FOR A CONTRACEPTIVE PATCH WHICH SUCCESSFULLY CONCLUDED CLINICAL TRIALS. P ...

    SBIR Phase II 1993 Department of Health and Human Services
  5. DEVELOPMENT AND TESTING OF NEW SPERMICIDE SUPPOSITORY

    SBC: BIOTEK, INC.            Topic: N/A

    WE WILL EVALUATE THE DURATION OF EFFICACY OF A BIOERODIBLE CONTRACEPTIVE SPERMICIDE SUPPOSITORY IN ANIMALS. WE SEEK TO OPTIMIZE THE FORMULATION TO RELEASE SPERMICIDE OVER A PERIOD OF 12-16 HOURS IN THE LIMITED FLUID ENVIRONMENT OF THE VAGINA. THE OLD AND NEW FORMULATION WILL BE SCREENED IN RABBITS AND THE FINAL FORMULATION TESTED IN MONKEYS.

    SBIR Phase II 1993 Department of Health and Human Services
  6. PRODUCTION OF POLYCLONAL ANTIBODIES IN RABBITS

    SBC: BIOTEK, INC.            Topic: N/A

    CHOLINESTERASES ARE WIDELY DISTRIBUTED THROUGHOUT THE BODY. THEY HYDROLYZE ACETYLCHOLINE (ACH), A COMPOUND WHICH SERVES ALSO AS THE NEUROHUMORAL AGENT IN PERIPHERAL JUNCTION TRANSMISSION. CHOLINESTERASES ARE KNOWN TO BE CRUCIAL FOR CHOLINERGIC NEUROTRANSMISSION AND OCCUR AT HIGH CONCENTRATIONS IN THE IMMEDIATE VICINITY OF NERVE ENDINGS WHERE THEY HYDROLYZE ACH IN LESS THAN A MILLISECOND. RESEARCH ...

    SBIR Phase II 1993 Department of DefenseArmy
  7. Development of a Naltrexone Microcapsule Injection

    SBC: BIOTEK, INC.            Topic: N/A

    N/A

    SBIR Phase I 1993 Department of Health and Human Services
  8. Injectable Microcapsule for Estrogen Replacement Therapy

    SBC: BIOTEK, INC.            Topic: N/A

    N/A

    SBIR Phase I 1993 Department of Health and Human Services
  9. DNA-based Amplification Assay for Chlamydia trachomatis

    SBC: Biotronics Corporation            Topic: N/A

    We will develop a rapid, specific, sensitive, and homogeneous detection system based on DNA amplification for the diagnosis of Chlamydia trachomatis infections in symptomatic as well as asymptomatic individuals. Chlamydia trachomatis is a major human pathogen responsible for a wide range of infections including lymphogranuloma venereum, trachoma, inclusion conjunctivitis and genital tract infectio ...

    SBIR Phase I 1993 Department of Health and Human Services
  10. A LOW NITROGEN OXIDE BURNER FOR COAL COMBUSTION

    SBC: BLAZETECH CORPORATION            Topic: N/A

    THIS PROJECT WILL INVESTIGATE AN INNOVATIVE, PROPRIETARY BURNER DESIGN FOR NITRIC OXIDES (NOX) FROM THE COMBUSTION OF FOSSIL FUELS. THE PROPOSED BURNER INCORPORATES, FOR THE FIRST TIME, TWO WELL-KNOWN METHODS OF NOX) REDUCTION IN A SINGLE DESIGN. IN PHASE I, A SCALE MODEL OF THIS BURNER WILL BE CONSTRUCTED FOR PULVERIZED COAL, AND TESTED IN AN EXISTING 3 MILLION BTU/HR COMBUSTION FACILITY. FLUE GA ...

    SBIR Phase I 1993 Department of Energy
US Flag An Official Website of the United States Government